Results 261 to 270 of about 6,034,145 (367)
Clinical Phenotyping of Long COVID Patients Evaluated in a Specialized Neuro‐COVID Clinic
ABSTRACT Objective To report Long COVID characteristics and longitudinal courses of patients evaluated between 4/14/21–4/14/22 at the University of Pennsylvania Neurological COVID Clinic (PNCC), including clinical symptoms, neurological examination findings, and neurocognitive screening tests from a standardized PNCC neurological evaluation approach ...
Luana D. Yamashita+7 more
wiley +1 more source
Microbiome data management in action workshop: Atlanta, GA, USA, June 12-13, 2024. [PDF]
Kelliher JM+36 more
europepmc +1 more source
Scientific Issues in Relation to Lakewide Management Plans: Linking Science and Policy
Michael Gilbertson+2 more
openalex +1 more source
ABSTRACT Objective Post‐discharge management and outcomes of acute symptomatic seizures (ASyS) remain underexplored. We analyzed post‐discharge ASM management and outcomes in ASyS patients undergoing continuous EEG (cEEG), including the role of outpatient care through a post‐acute symptomatic seizure (PASS) clinic. Methods We performed a single‐center,
Vineet Punia+10 more
wiley +1 more source
Correction: Toward Personalized Digital Experiences to Promote Diabetes Self-Management: Mixed Methods Social Computing Approach. [PDF]
Singh T+5 more
europepmc +1 more source
ABSTRACT Objective Quantitative markers of cortical excitability may help identify responders to anti‐seizure medications (ASMs). We studied the relationship between ASM load and two electroencephalography (EEG) markers of cortical excitability in people with refractory epilepsy. Methods We included individuals with refractory focal epilepsy undergoing
Silvano R. Gefferie+7 more
wiley +1 more source
One Size Does Not Fit All: The Need for Sex-Specific Precision Medicine in Diabetes Technology. [PDF]
Hossmann S+33 more
europepmc +1 more source
ABSTRACT Objective Increasing evidence shows that patients with intracerebral hemorrhage (ICH) can achieve better‐than‐expected outcomes with aggressive therapy. However, real‐world long‐term data, patient‐centered outcomes, and societal measures after maximal ICH treatment are lacking.
Anne Mrochen+11 more
wiley +1 more source